Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.

Authors :: Rio-Vilariño A
Cenigaonandia-Campillo A
García-Bautista A
Mateos-Gómez PA
Schlaepfer MI
Del Puerto-Nevado L
Aguilera O
García-García L
Galeano C
de Miguel I
Serrano-López J
Baños N
Fernández-Aceñero MJ
Lacal JC
Medico E
García-Foncillas J
Cebrián A
Source :: British journal of cancer [Br J Cancer] 2024 May; Vol. 130 (8), pp. 1414.
Publication Year :: 2024

Full Text Access

Tools